MedPath

ONO-7684

Generic Name
ONO-7684

A Two-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-7684 in Healthy Adult Volunteers

Phase 1
Completed
Conditions
Venous Thromboembolism
Interventions
Drug: ONO-7684 Placebo
First Posted Date
2019-04-18
Last Posted Date
2019-12-09
Lead Sponsor
Ono Pharmaceutical Co. Ltd
Target Recruit Count
72
Registration Number
NCT03919890
Locations
🇬🇧

Hammersmith Medicines Research (HMR), London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath